Get Started Administration Instructions FAQ Book Online

And Now for a Brief History Lesson on Semaglutide

Once upon a time, a team of Danish researchers discovered that the compound called Liraglutide, a daily subcutaneous—or injectible—diabetes medication, could be modified into what they called semaglutide, only requiring a once-weekly dosing. What started as a humble diabetic symptom management operation was soon to change the lives of those suffering from obesity, diabetes, and other metabolism-related issues globally.

The use of subcutaneous injections to treat symptoms of diabetes has been used since 1922, when the first insulin injection was administered to save the life of then-14-year-old Leonard Thompson. A lot has happened in the last century regarding diabetes medications and their uses, and significant technological strides have been made to serve more than just the diabetic population.

Medications such as Ozempic and Wegovy are among the largest manufacturers of diabetes medication. These medications mimic hormones the human metabolic system already produces to treat Type 2 diabetes. Since the researchers at Novo Nordisk developed the semaglutide variation on the family of diabetes medications in 2012, it has been used to treat difficulties associated with diabetes. 

But the doctors, scientists, and diabetics using, prescribing, and testing noted a curious side effect of the medication. You got it, folks: weight loss.

Doctors prescribing semaglutides found that the medication works by increasing the frequency of a specific peptide available in the body. These peptides—hormone-like agents, also known as GLP-1 or glucagon-like peptide-1 agonists—bind to receptors that signal satiety and mimic the effects of GLP-1. This ultimately causes the body to increase insulin and decrease blood sugar. The entire process works to curb appetite and cravings effectively.

Making Weight Loss History

As both medical professionals and individuals with diabetes have observed the impact of GLP-1 agonists on weight, there has been a persistent advocacy for the use of these medications in the context of weight loss. Following numerous years of clinical tests and trials, semaglutide received official recognition as a weight loss treatment in June of 2021. Subsequently, semaglutides became readily accessible to both diabetic and non-diabetic individuals..

To put it simply, the transition from initial development to a fully recognized solution for weight management has been a century-long journey for semaglutides. Fortunately, we find ourselves living in an era where these technological advancements are available to us, marking a significant milestone for these innovations. There's no need to resort to underground sources for glucagon-like peptides—everything is above board.

Call Us Today if Convenient Weight Loss is Your Goal

Call Weight Loss Shots today to speak with a member of our fat-loss team to see if you qualify for the groundbreaking weight-loss medication that is here to stay.

We will set you up with a free virtual consultation with one of our PAs, during which we will review your medical history and weight loss goals to determine whether you could be a candidate for semaglutide weight loss shots.

If easy, convenient weight loss is your goal, we here at Weight Loss Shots know we can help you get the results you need to feel like your best self. Call today to learn more and see if we service your state—even if we don’t, we want to hear from you. Our program is entirely virtual, on your schedule, wherever you may be. Though we stay in Austin physically, we would love to beam our weight loss powers to those in need nationwide.

Banner media

*Supply note: Our semaglutide is sourced separately from that which people with diabetes use. Therefore, our weight loss shots do not affect the supply and availability to people with diabetic needs.

Schedule a freeConsultation

Are you interested in trying our weight loss shots program? Schedule your free consultation with one of our weight loss experts today. We would be happy to answer any questions you may have and determine whether semaglutide is right for you.

Contact Us
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at 512.812.7024.
Contact Us